Sanofi to Pay $100 Million to Settle Zantac Cancer Lawsuits April 23, 2024 By Jef Feeley Sanofi will pay more than $100 million to settle about 4,000 lawsuits accusing the French drugmaker of failing to warn...
Drugmaker Sanofi Ordered to Compensate French Family for Epilepsy Drug Side Effects May 16, 2022 PARIS – A French court has ordered Sanofi to pay more than 400,000 euros ($416,440) in damages to a family...
French Court Allows Class Action Against Sanofi Over Its Epilepsy Drug Depakine January 5, 2022 By Marthe Fourcade and Gaspard Sebag A French court ruled that families of children who suffered side effects from the epilepsy medicine Depakine can join in...
Drugmakers Plan to Raise Prices in New Year: Reuters, 3 Axis Advisors January 4, 2021 By Michael Erman and Carl O'Donnell Drugmakers including Pfizer Inc., Sanofi SA, and GlaxoSmithKline Plc plan to raise U.S. prices on more than 300 drugs in...
Limited Liability Protection for Drugmakers Hampers EU Coronavirus Vaccine Deals August 26, 2020 By Francesco Guarascio The European Union is offering only partial protection to vaccine makers against legal risks from side-effects of their potential COVID-19...
Sanofi Executive, Fired in France for Sexting, Sues for $1.5 Million March 7, 2018 By Gaspard Sebag First he sent lewd texts. Then he got fired. Then he sued. The case of an alleged sex pest at...
French Regulator Links Sanofi Epilepsy Drug to Birth Defects April 21, 2017 By Matthias Blamont Up to 4,100 children in France suffered major malformations in the womb after their mothers took a treatment against epilepsy...
French Women Took Sanofi Epilepsy Drug Despite Risk to Fetuses: Report August 11, 2016 By Gerard Bon and Geert De Ciercq More than 10,000 pregnant women in France took Sanofi’s anti-epilepsy drug Depakine between 2007 and 2014 although the risk of...